On October 25, 2019 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, reported that the company is scheduled to present in the following investor conferences (Press release, Ideaya Biosciences, OCT 25, 2019, View Source [SID1234542537]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Stifel 2019 Healthcare Conference in New York City, NY. The company is scheduled to present on Wednesday, November 20th at 3:35 pm ET (12:35 pm PST)
Jefferies 2019 London Healthcare Conference in London, United Kingdom. The company is scheduled to present on Thursday, November 21st at 7:20am GMT+1 (11:20 pm PST)